Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Saito, Takefumi"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 161
Tytuł:
Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.
Autorzy:
Saito T; Department of Respiratory Medicine, National Hospital Organization Ibarakihigashi National Hospital, 825 Terunuma Tokaimura, Naka-gun, Ibaraki, Japan. />Hasunuma T
Pokaż więcej
Źródło:
Clinical drug investigation [Clin Drug Investig] 2012 Jan 01; Vol. 32 (1), pp. 51-61.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Asthma/*drug therapy
Bronchodilator Agents/*therapeutic use
Budesonide/*therapeutic use
Ethanolamines/*therapeutic use
Adolescent ; Adult ; Aged ; Bronchodilator Agents/administration & dosage ; Budesonide/administration & dosage ; Cross-Over Studies ; Double-Blind Method ; Drug Combinations ; Ethanolamines/administration & dosage ; Formoterol Fumarate ; Humans ; Japan ; Middle Aged ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features
Autorzy:
Sekine, Akimasa
Kato, Terufumi
Hagiwara, Eri
Shinohara, Takeshi
Komagata, Takanobu
Iwasawa, Tae
Satoh, Hiroaki
Tamura, Katsumi
Kasamatsu, Tomotaka
Hayashihara, Kenji
Saito, Takefumi
Takahashi, Hiroshi
Ogura, Takashi
Pokaż więcej
Źródło:
Lung Cancer (01695002). Jul2012, Vol. 77 Issue 1, p64-69. 6p.
Czasopismo naukowe
Szczegóły
Tytuł:
Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.
Autorzy:
Kurishima K; Tsukuba University Hospital, Tsukuba, Ibaraki 305-8576, Japan.
Satoh H; Mito Medical Center, University of Tsukuba, Mito, Ibaraki 310-0015, Japan.
Kaburagi T; Ibaraki Prefectural Central Hospital and Regional Cancer Center, Kasama, Ibaraki 309-1793, Japan.
Nishimura Y; Mito Chuo Hospital, Mito, Ibaraki 311-1135, Japan.
Shinohara Y; Tsuchiura Kyodo General Hospital and Regional Cancer Center, Tsuchiura, Ibaraki 300-0053, Japan.
Inagaki M; Tsuchiura Kyodo General Hospital and Regional Cancer Center, Tsuchiura, Ibaraki 300-0053, Japan.
Endo T; National Hospital Organisation, Mito Medical Center Hospital, Mito, Ibaraki 311-3193, Japan.
Saito T; Ibaraki Higashi National Hospital, Tokai, Ibaraki 319-1113, Japan.
Hayashihara K; Ibaraki Higashi National Hospital, Tokai, Ibaraki 319-1113, Japan.
Hizawa N; Tsukuba University Hospital, Tsukuba, Ibaraki 305-8576, Japan.
Nakamura H; Tokyo Medical University, Ibaraki Medical Center Hospital, Ami, Ibaraki 300-0395, Japan.
Nawa T; Hitachi General Hospital, Hitachi, Ibaraki 317-0077, Japan.
Kagohashi K; Mito Medical Center, University of Tsukuba, Mito, Ibaraki 310-0015, Japan.
Kishi K; Tokyo Medical University, Ibaraki Medical Center Hospital, Ami, Ibaraki 300-0395, Japan.
Ishikawa H; Tsukuba Medical Center Hospital and Regional Cancer Center, Tsukuba, Ibaraki 305-8558, Japan.
Ichimura H; Tsukuba Medical Center Hospital and Regional Cancer Center, Tsukuba, Ibaraki 305-8558, Japan.
Hashimoto T; Mito Saiseikai General Hospital, Mito, Ibaraki 311-4198, Japan.
Sato Y; Tsukuba University Hospital, Tsukuba, Ibaraki 305-8576, Japan.
Sakai M; Tsukuba University Hospital, Tsukuba, Ibaraki 305-8576, Japan.
Kamiyama K; Tsukuba Memorial Hospital, Tsukuba, Ibaraki 300-2622, Japan.
Matsumura T; Ibaraki Seinan Medical Center Hospital, Sakai, Osaka 306-0433, Japan.
Unoura K; JA Toride Medical Center, Toride, Ibaraki 302-0022, Japan.
Fukuoka T; JA Toride Medical Center, Toride, Ibaraki 302-0022, Japan.
Uchiumi K; Ibaraki Prefectural Central Hospital and Regional Cancer Center, Kasama, Ibaraki 309-1793, Japan.
Nomura A; Ibaraki Seinan Medical Center Hospital, Sakai, Osaka 306-0433, Japan.
Furukawa K; Tokyo Medical University, Ibaraki Medical Center Hospital, Ami, Ibaraki 300-0395, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2013 Sep; Vol. 1 (5), pp. 828-832. Date of Electronic Publication: 2013 Jul 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension.
Autorzy:
Hatano, Masaru
Yamada, Hidehiro
Fukuda, Keiichi
Yoshioka, Koichiro
Funauchi, Masanori
Kuwana, Masataka
Sata, Masataka
Taniguchi, Mitsugu
Nakanishi, Norifumi
Saito, Takefumi
Saji, Tsutomu
Sasayama, Shigetake
Pokaż więcej
Temat:
ENDOTHELIN receptors
HEMODYNAMICS
JAPANESE people
SYMPTOMS
PULMONARY artery diseases
HYPERTENSION
DISEASES
Źródło:
Heart & Vessels; Nov2015, Vol. 30 Issue 6, p798-804, 7p
Czasopismo naukowe
Szczegóły
Tytuł:
Efficacy of first-line erlotinib in non-small cell lung cancer patients undergoing dose reduction and those with a low body surface area: A population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.
Autorzy:
Inagaki M; Divisions of Thoracic Surgery and Respiratory Medicine, Tsuchiura Kyodo General Hospital and Regional Cancer Center, Tsuchiura, Ibaraki 300-0053, Japan.
Shinohara Y; Divisions of Thoracic Surgery and Respiratory Medicine, Tsuchiura Kyodo General Hospital and Regional Cancer Center, Tsuchiura, Ibaraki 300-0053, Japan.
Kaburagi T; Division of Respiratory Medicine, Ibaraki Prefectural Central Hospital and Regional Cancer Center, Kasama, Ibaraki 309-1793, Japan.
Homma S; Division of Respiratory Medicine, Faculty of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Hizawa N; Division of Respiratory Medicine, Faculty of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Nakamura H; Divisions of Thoracic Surgery and Respiratory Medicine, Tokyo Medical University, Ibaraki Medical Center Hospital, Ami, Ibaraki 300-0395, Japan.
Hayashihara K; Division of Respiratory Medicine, Ibaraki Higashi National Hospital, Tokai, Ibaraki 319-1113, Japan.
Saito T; Division of Respiratory Medicine, Ibaraki Higashi National Hospital, Tokai, Ibaraki 319-1113, Japan.
Ishikawa H; Division of Respiratory Medicine, Tsukuba Medical Center Hospital and Regional Cancer Center, Tsukuba, Ibaraki 305-8558, Japan.
Ichimura H; Divisions of Thoracic Surgery and Respiratory Medicine, Hitachi General Hospital, Hitachi, Ibaraki 317-0077, Japan.
Nawa T; Divisions of Thoracic Surgery and Respiratory Medicine, Hitachi General Hospital, Hitachi, Ibaraki 317-0077, Japan.
Kikuchi N; Division of Respiratory Medicine, Kasumigaura Medical Center, Tsuchiura, Ibaraki 300-0812, Japan.
Miyazaki K; Division of Respiratory Medicine, Ryugasaki Saiseikai General Hospital, Ryugasaki, Ibaraki 301-0854, Japan.
Kodama T; Division of Respiratory Medicine, Ryugasaki Saiseikai General Hospital, Ryugasaki, Ibaraki 301-0854, Japan.
Kamiyama K; Division of Thoracic Surgery, Tsukuba Kinen General Hospital, Tsukuba, Ibaraki 300-2622, Japan.
Satoh H; Division of Respiratory Medicine, Mito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki 310-0015, Japan.
Furukawa K; Divisions of Thoracic Surgery and Respiratory Medicine, Tokyo Medical University, Ibaraki Medical Center Hospital, Ami, Ibaraki 300-0395, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2016 Mar; Vol. 4 (3), pp. 425-428. Date of Electronic Publication: 2015 Dec 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
S-1-containing chemotherapy for patients with non-small-cell lung cancer: A population-based observational study by the Ibaraki thoracic integrative (POSITIVE) research group.
Autorzy:
Inagaki M; Tsuchiura Kyodo General Hospital and Regional Cancer Center, Tsuchiura, Ibaraki 300-0053, Japan.
Shinohara Y; Tsuchiura Kyodo General Hospital and Regional Cancer Center, Tsuchiura, Ibaraki 300-0053, Japan.
Kaburagi T; Ibaraki Prefectural Central Hospital and Regional Cancer Center, Kasama, Ibaraki 309-1793, Japan.
Endo T; Mito Medical Center Hospital, Mito, Ibaraki 311-3193, Japan.
Homma S; Faculty of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Hizawa N; Faculty of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Kishi K; Tokyo Medical University, Ibaraki Medical Center Hospital, Ami, Ibaraki 300-0395, Japan.
Nakamura H; Tokyo Medical University, Ibaraki Medical Center Hospital, Ami, Ibaraki 300-0395, Japan.
Hayashihara K; Ibaraki Higashi National Hospital, Tokai, Ibaraki 319-1113, Japan.
Saito T; Ibaraki Higashi National Hospital, Tokai, Ibaraki 319-1113, Japan.
Kurishima K; Tsukuba Medical Center Hospital and Regional Cancer Center, Tsukuba, Ibaraki 305-8558, Japan.
Ishikawa H; Tsukuba Medical Center Hospital and Regional Cancer Center, Tsukuba, Ibaraki 305-8558, Japan.
Ichimura H; Hitachi General Hospital, Hitachi, Ibaraki 317-0077, Japan.
Nawa T; Hitachi General Hospital, Hitachi, Ibaraki 317-0077, Japan.
Kikuchi N; Kasumigaura Medical Center, Tsuchiura, Ibaraki 300-0812, Japan.
Miyazaki K; Ryugasaki Saiseikai General Hospital, Ryugasaki, Ibaraki 301-0854, Japan.
Kodama T; Ryugasaki Saiseikai General Hospital, Ryugasaki, Ibaraki 301-0854, Japan.
Satoh H; Division of Respiratory Medicine, Μito Medical Center, Institute of Clinical Medicine, University of Tsukuba, Mito, Ibaraki 310-0015, Japan.
Furukawa K; Tokyo Medical University, Ibaraki Medical Center Hospital, Ami, Ibaraki 300-0395, Japan.
Pokaż więcej
Źródło:
Molecular and clinical oncology [Mol Clin Oncol] 2016 Jun; Vol. 4 (6), pp. 1025-1030. Date of Electronic Publication: 2016 Mar 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan.
Autorzy:
Yi L; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan.; Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose, Japan.; Department of Basic Mycobacteriology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Sasaki Y; Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Nagai H; Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, Kiyose, Japan.
Ishikawa S; Department of Respiratory Medicine, National Hospital Organization Chiba Higashi National Hospital, Chiba, Japan.
Takamori M; Department of Respiratory Medicine, Tokyo Metropolitan Tama Medical Centre, Fuchu, Japan.
Sakashita K; Department of Basic Mycobacteriology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.; Department of Respiratory Medicine, Tokyo Metropolitan Tama Medical Centre, Fuchu, Japan.
Saito T; Department of Respiratory Medicine, National Hospital Organization Ibaraki Higashi National Hospital, Ibaraki, Japan.
Fukushima K; Department of Respiratory Medicine, Nagasaki Genbaku Isahaya Hospital, Nagasaki, Japan.
Igarashi Y; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Aono A; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Chikamatsu K; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Yamada H; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Takaki A; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Mori T; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Mitarai S; Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan.; Department of Basic Mycobacteriology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Jul 29; Vol. 6, pp. 30617. Date of Electronic Publication: 2016 Jul 29.
Typ publikacji:
Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Interferon-gamma Release Tests/*methods
Tuberculosis/*diagnosis
Adult ; Aged ; Female ; Humans ; Japan ; Male ; Middle Aged ; ROC Curve ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 161

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies